share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Kewalramani Reshma

SEC announcement ·  Jun 15 04:28
Summary by Futu AI
Reshma Kewalramani, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on 06/12/2024 involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Kewalramani holding a total of 186,002 direct shares post-transaction. The action reflects a significant increase in Kewalramani's stake in the company, although the transaction price was not disclosed.
Reshma Kewalramani, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on 06/12/2024 involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Kewalramani holding a total of 186,002 direct shares post-transaction. The action reflects a significant increase in Kewalramani's stake in the company, although the transaction price was not disclosed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.